Filter Results:
(2,083)
Show Results For
- All HBS Web
(2,083)
- People (8)
- News (589)
- Research (986)
- Events (3)
- Multimedia (25)
- Faculty Publications (581)
Show Results For
- All HBS Web
(2,083)
- People (8)
- News (589)
- Research (986)
- Events (3)
- Multimedia (25)
- Faculty Publications (581)
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details
Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry
Henderson, Rebecca, and Ian Cockburn. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry." In Innovation Policy and the Economy, Volume 1, edited by Adam B. Jaffe, Josh Lerner, and Scott Stern, 1–34. MIT Press, 2001.
- 24 Jan 2017
- First Look
First Look at New Research: January 24, 2017
Yoshimi Anzai, Marta E. Heilbrun, Derek Haas, Luca Boi, Kirk Moshre, Satoshi Minoshima, and Vivian S. Lee Abstract—The lack of understanding the true costs (not charges) of delivering health care services poses tremendous challenges in... View Details
Keywords: Sean Silverthorne
William A. Sahlman
William Sahlman is a Baker Foundation Professor of Business Administration at Harvard Business School.
Mr. Sahlman received an A.B. degree in Economics from Princeton University (1972), an M.B.A. from Harvard University (1975), and a Ph.D. in Business... View Details
Keywords: health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care
- Web
Career Path - MBA
Products Entertainment / Media Financial Services Health Care Manufacturing Nonprofit / Government Retail / Trading Services Technology Student Insights & Career Advice Harvard Business School’s Armed Forces... View Details
- July 2000 (Revised September 2005)
- Case
Guidant: Radiation Therapy
Describes a potential new approach to treating cardiac disease--radiation therapy. Guidant, a leading medical device maker, faces a choice about whether to pursue this new and risky technology and, if so with what strategy. View Details
Keywords: Entrepreneurship; Decisions; Innovation Strategy; Health Care and Treatment; Product Design; Corporate Strategy; Medical Specialties; Health Industry; Health Industry
Roberts, Michael J., and Diana S. Gardner. "Guidant: Radiation Therapy." Harvard Business School Case 801-040, July 2000. (Revised September 2005.)
- Web
Faculty & Research
deployment of this technology at scale. We begin to address this urgent question by focusing on the context of mental health and “companion AI”: applications designed to provide consumers with synthetic... View Details
Derek C. M. van Bever
Derek van Bever is a Senior Lecturer in the General Management Unit of Harvard Business School. He teaches courses in both years of the MBA program (“Leadership and Corporate Accountability” in the first-year required curriculum and “Building and Sustaining a... View Details
- Program
Leading in the Digital Era
Summary New digital technologies, data analytics, and new applications of artificial intelligence (AI) are rapidly changing the expectations of customers, employees, and other stakeholders. Though many of today's executives are neither View Details
- 02 Nov 2017
- News
Could a Hackathon Help Solve the Heroin Crisis?
- 2008
- Book
On Competition
By: M. E. Porter
Competition is one of society's most powerful forces for making things better in many fields of human endeavor. The study of competition and the creation of value, in their full richness, have preoccupied me for several decades. Competition is pervasive, whether it... View Details
Porter, M. E. On Competition. Updated and Expanded Ed. Boston: Harvard Business School Publishing, 2008.
- 2016
- Book
Innovation Policy and the Economy, Volume 17
By: Shane Greenstein, Josh Lerner and Scott Stern
The seventeenth volume of the National Bureau of Economic Research’s Innovation Policy and the Economy provides an accessible forum for bringing the work of leading academic researchers to an audience of policymakers and those interested in the interaction... View Details
Greenstein, Shane, Josh Lerner and Scott Stern, eds. Innovation Policy and the Economy, Volume 17. Chicago: University of Chicago Press, 2016.
- Web
FAQs - MBA
Boston’s biotech, research and entrepreneurial ecosystems? What resources did MS/MBA students have and are there opportunities outside the classroom? The MS/MBA Biotech program is part of a larger community of health care interested... View Details
- 05 Aug 2020
- News
Remote work really does mean longer days -- and more meetings
- October 2022
- Background Note
Note on Cyberattacks and Regulatory Regimes
Describes common types of cyberattacks on enterprises and their costs, as well as the fragmentary regulatory regimes through which U.S. states and regulatory agencies at the start of 2021 attempted to encourage disclosure of cyberattacks and to pursue enforcement... View Details
Keywords: Regulations; Regulatory Agencies; Cyberattacks; Governance; Corporate Disclosure; Cybersecurity; Information Technology Industry; Information Technology Industry; Information Technology Industry; Information Technology Industry; United States
Nagle, Frank, George A. Riedel, William R. Kerr, and David Lane. "Note on Cyberattacks and Regulatory Regimes." Harvard Business School Background Note 723-392, October 2022.
- August 1995 (Revised June 1997)
- Case
Hillcrest Research Associates, Inc.
Hillcrest designs and administers testing procedures for drugs to determine whether they pass FDA specifications. As the company grows, it encounters problems with information technology and with the clinical research associates, who feel pressured to report more... View Details
Keywords: Growth Management; Information Technology; Health Testing and Trials; Pharmaceutical Industry
Barnes, Louis B. "Hillcrest Research Associates, Inc." Harvard Business School Case 496-021, August 1995. (Revised June 1997.)
- Web
Employment Data
Products 4% Entertainment / Media 1% Health Care 5% Investment Banking 3% Investment Management / Hedge Fund 6% Manufacturing 6% Nonprofit / Government 5% Other Financial Services 3% Private Equity 17% Retail 1% Services 2% View Details
- 17 May 2012
- News
OSHA's Safety Tests Protect Workers at Little Cost: Study
- March 2024
- Article
Differences in Care Team Response to Patient Portal Messages by Patient Race and Ethnicity
By: Mitchell Tang, Rebecca Mishuris, Lily Payvandi and Ariel Dora Stern
Importance: The COVID-19 pandemic was associated with substantial growth in patient portal messaging. Higher message volumes have largely persisted, reflecting a new normal. Prior work has documented lower message use by patients who belong to minoritized racial... View Details
Keywords: Health Pandemics; Technology Adoption; Prejudice and Bias; Equality and Inequality; Communication Technology; Race; Ethnicity; Health Industry
Tang, Mitchell, Rebecca Mishuris, Lily Payvandi, and Ariel Dora Stern. "Differences in Care Team Response to Patient Portal Messages by Patient Race and Ethnicity." JAMA Network Open 7, no. 3 (March 2024).
- Web
HBS Working Knowledge – Harvard Business School Faculty Research
could other businesses learn from his ascent? What Will It Take to Confront the Invisible Mental Health Crisis in Business? by Kara Baskin 09 NOV 2023 | HBS Case The pressure to do more, to be more, is fueling its own silent epidemic.... View Details